Skip to main navigation
About
Overview
Values
Management
Board of Directors
Science
Atacicept in IgAN
Phase 2b Clinical Data
Phase 3 Clinical Trial
Atacicept in LN
MAU868
Publications
Patients
Careers
Investors
Overview
Stock Information
News & Events
Presentations
Financial Information
Analyst Coverage
Corporate Governance
Investor Resources
Contact
About
Overview
Values
Management
Board of Directors
Science
Atacicept in IgAN
Phase 2b Clinical Data
Phase 3 Clinical Trial
Atacicept in LN
MAU868
Publications
Patients
Careers
Investors
Overview
Stock Information
News & Events
Presentations
Financial Information
Analyst Coverage
Corporate Governance
Investor Resources
Contact
Event Details
January 4, 2023 at 8:00 AM EST
ORIGIN Phase 2b Clinical Trial Week 24 Results
Listen to webcast
Top
